Evidence map›Paper›PMID 36615760›Full record

ArticleNutrients2022

Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia.

Brandon N VanderVeen, Thomas D Cardaci, Patrice Cunningham, Sierra J McDonald, Brooke M Bullard, Daping Fan, E Angela Murphy, Kandy T Velázquez

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Cannabis improves metabolic dysfunction and macrophage signatures in obese mice.American journal of physiology. Cell physiology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Diversity in chemotherapy-induced cachexia.American journal of physiology. Cell physiology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brandon N VanderVeenDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-4535-0544
Thomas D CardaciDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-4339-819X
Patrice CunninghamDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Sierra J McDonaldDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Brooke M BullardDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Daping FanAcePre, LLC, Columbia, SC 29209, USA.
E Angela MurphyDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Kandy T VelázquezDepartment of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0003-2427-165X
University of South Carolina · US

Funding

The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral painR00AT009206 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI VELAZQUEZ, KANDY T · 2019 to 2021
$747k
Development of Dietary Quercetin to Treat Muscle Wasting DisordersR43AT011171 · NCCIH · ACEPRE, LLC · PI VANDERVEEN, BRANDON, VELAZQUEZ, KANDY T · 2020 to 2021
$352k
The effects of Ojeok-san on neuro-immune interactions in cancer-induced visceral painK99AT009206 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI VELAZQUEZ, KANDY T · 2017 to 2018
$199k
NCCIH NIH HHS K99 AT009206NCCIH NIH HHS R00 AT009206NCCIH NIH HHS R43 AT011171NCCIH NIH HHS R43AT011171
6 · The paper itself

Abstract

A cachexia diagnosis is associated with a doubling in hospital stay and increased healthcare cost for cancer patients and most cachectic patients do not survive treatment. Unfortunately, complexity in treating cachexia is amplified by both the underlying malignancy and the anti-cancer therapy which can independently promote cachexia. Quercetin, an organic polyphenolic flavonoid, has demonstrated anti-inflammatory and antioxidant properties with promise in protecting against cancer and chemotherapy-induced dysfunction; however, whether quercetin is efficacious in maintaining muscle mass in tumor-bearing animals receiving chemotherapy has not been investigated. C26 tumor-bearing mice were given 5-fluorouracil (5FU; 30 mg/kg of lean mass i.p.) concomitant with quercetin (Quer; 50 mg/kg of body weight via oral gavage) or vehicle. Both C26 + 5FU and C26 + 5FU + Quer had similar body weight loss; however, muscle mass and cross-sectional area was greater in C26 + 5FU + Quer compared to C26 + 5FU. Additionally, C26 + 5FU + Quer had a greater number and larger intermyofibrillar mitochondria with increased relative protein expression of mitochondrial complexes V, III, and II as well as cytochrome c expression. C26 + 5FU + Quer also had increased MFN1 and reduced FIS1 relative protein expression without apparent benefits to muscle inflammatory signaling. Our data suggest that quercetin protected against cancer and chemotherapy-induced muscle mass loss through improving mitochondrial homeostatic balance.

Indexed as

Antineoplastic AgentsNeoplasmsAnimalsCachexiaDisease Models, AnimalFluorouracilMiceMitochondriaMuscle, SkeletalQuercetinAntineoplastic AgentsFluorouracilQuercetincachexiacancerchemotherapycomplementary medicinemitochondrianutraceuticalsskeletal muscle

Identifiers

PMID36615760
PMCPMC9823918
OpenAlexW4313259776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.